[1] GLYN-JONES S, PALMER AJ, AGRICOLA R, et al. Osteoarthritis. Lancet. 2015;386(9991):376-387.
[2] DWIVEDI G, FLAMAN L, ALAYBEYOGLU B, et al. Inflammatory cytokines and mechanical injury induce post-traumatic osteoarthritis-like changes in a human cartilage-bone-synovium microphysiological system. Arthritis Res Ther. 2022;24(1):198.
[3] VARGAS NEGRÍN F, MEDINA ABELLÁN MD, HERMOSA HERNÁN JC, et al. Treatment of patients with osteoarthritis. Aten Primaria. 2014;46 Suppl 1(Suppl 1):39-61.
[4] HUSSAIN SM, NEILLY DW, BALIGA S, et al. Knee osteoarthritis: a review of management options. Scott Med J. 2016;61(1):7-16.
[5] KATZ JN, ARANT KR, LOESER RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568-578.
[6] ZHANG R, MA J, HAN J, et al. Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis. Am J Transl Res. 2019;11(10): 6275-6289.
[7] YU M, WANG D, CHEN X, et al. BMSCs-derived Mitochondria Improve Osteoarthritis by Ameliorating Mitochondrial Dysfunction and Promoting Mitochondrial Biogenesis in Chondrocytes. Stem Cell Rev Rep. 2022;18(8):3092-3111.
[8] JEVOTOVSKY DS, ALFONSO AR, EINHORN TA, et al. Osteoarthritis and stem cell therapy in humans: a systematic review. Osteoarthritis Cartilage. 2018;26(6):711-729.
[9] GAO Q, WANG L, WANG S, et al. Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation. Front Cell Dev Biol. 2022;9:787118.
[10] ZHUANG J, HANG R, SUN R, et al. Multifunctional exosomes derived from bone marrow stem cells for fulfilled osseointegration. Front Chem. 2022;10:984131.
[11] HE L, HE T, XING J, et al. Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis. Stem Cell Res Ther. 2020;11(1):276.
[12] HA DH, KIM HK, LEE J, et al. Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration. Cells. 2020;9(5):1157.
[13] MAQSOOD M, KANG M, WU X, et al. Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Life Sci. 2020;256:118002.
[14] CETIN Z, ILKER SAYGILI E, YILMAZ M. Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes. Front Biosci (Landmark Ed). 2021;26(3):444-467.
[15] ZHAO X, WU D, MA X, et al. Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake. Biomed Pharmacother. 2020;128:110237.
[16] XU M, FENG T, LIU B, et al. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics. 2021;11(18):8926-8944.
[17] LUAN X, SANSANAPHONGPRICHA K, MYERS I, et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754-763.
[18] ZHU S, QIU H, BENNETT S, et al. Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease. Cell Mol Life Sci. 2019;76(22): 4493-4502.
[19] SUZUKI F. Roles of cartilage matrix proteins, chondromodulin-I and -II, in endochondral bone formation: a review. Connect Tissue Res. 1996; 35(1-4):303-307.
[20] HIRAKI Y, SHUKUNAMI C. Chondromodulin-I as a novel cartilage-specific growth-modulating factor. Pediatr Nephrol. 2000;14(7):602-605.
[21] ZHU Y, ZHANG Y, LIU Y, et al. The influence of Chm-I knockout on ectopic cartilage regeneration and homeostasis maintenance. Tissue Eng Part A. 2015;21(3-4):782-792.
[22] HAYAMI T, FUNAKI H, YAOEDA K, et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol. 2003;30(10): 2207-2217.
[23] YUE F, JOHKURA K, TOMOTSUNE D, et al. Bone marrow stromal cells as an inducer for cardiomyocyte differentiation from mouse embryonic stem cells. Ann Anat. 2010;192(5):314-321.
[24] KARIM A, HALL AC. Chondrocyte Morphology in Stiff and Soft Agarose Gels and the Influence of Fetal Calf Serum. J Cell Physiol. 2017;232(5): 1041-1052.
[25] WANG BW, JIANG Y, YAO ZL, et al. Aucubin Protects Chondrocytes Against IL-1β-Induced Apoptosis In Vitro And Inhibits Osteoarthritis In Mice Model. Drug Des Devel Ther. 2019;13:3529-3538.
[26] JIANG Y, TUAN RS. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol. 2015;11(4):206-212.
[27] LOESER RF, COLLINS JA, DIEKMAN BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412-420.
[28] GRÄSSEL S, MUSCHTER D. Recent advances in the treatment of osteoarthritis. F1000Res. 2020;9:F1000 Faculty Rev-325.
[29] MIANEHSAZ E, MIRZAEI HR, Mahjoubin-Tehran M, et al. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther. 2019;10(1):340.
[30] ZHANG S, TEO KYW, CHUAH SJ, et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials. 2019;200:35-47.
[31] QIU B, XU X, YI P, et al. Curcumin reinforces MSC-derived exosomes in attenuating osteoarthritis via modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 signalling pathways. J Cell Mol Med. 2020; 24(18):10855-10865.
[32] TAO SC, YUAN T, ZHANG YL, et al. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7(1):180-195.
[33] ZHANG Y, BI J, HUANG J, et al. Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications. Int J Nanomedicine. 2020;15:6917-6934.
[34] WAN Z, DONG Y, WEI M, et al. Exosomes in Tumor Immunotherapy: Mediator, Drug Carrier, and Prognostic Biomarker. Adv Biosyst. 2020; 4(11):e2000061.
[35] KAHROBA H, HEJAZI MS, SAMADI N. Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cell Mol Life Sci. 2019;76(9):1747-1758.
[36] YIN L, LIU X, SHAO X, et al. The role of exosomes in lung cancer metastasis and clinical applications: an updated review. J Transl Med. 2021;19(1):312.
[37] NIE H, XIE X, ZHANG D, et al. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. Nanoscale. 2020; 12(2):877-887.
[38] XU H, XU B. BMSC-Derived Exosomes Ameliorate Osteoarthritis by Inhibiting Pyroptosis of Cartilage via Delivering miR-326 Targeting HDAC3 and STAT1//NF-κB p65 to Chondrocytes. Mediators Inflamm. 2021;2021:9972805.
[39] SHUKUNAMI C, OSHIMA Y, HIRAKI Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun. 2005;333(2):299-307.
[40] SHUKUNAMI C, HIRAKI Y. Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation. Osteoarthritis Cartilage. 2001;9 Suppl A:S91-101.
[41] YOSHIOKA M, YUASA S, MATSUMURA K, et al. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med. 2006;12(10):1151-1159.
[42] DENG B, CHEN C, GONG X, et al. Chondromodulin‑I expression and correlation with angiogenesis in human osteoarthritic cartilage. Mol Med Rep. 2017;16(2):2142-2148.
[43] FANG W, FRIIS TE, LONG X, et al. Expression of chondromodulin-1 in the temporomandibular joint condylar cartilage and disc. J Oral Pathol Med. 2010;39(4):356-360. |